| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0053 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |